[A naturalistic study on the effects of antidepressants (e. g. SSRI) and acetyl salicylic acid (ASA) on the self-rated perception of the psychotherapeutic process of inpatient psychosomatic treatment and its results: Could ASA be beneficial?]
Marius Binneböse, Jan Schott, Hannah Wallis, Christian Kaiser, Matthias Vogel
{"title":"[A naturalistic study on the effects of antidepressants (e. g. SSRI) and acetyl salicylic acid (ASA) on the self-rated perception of the psychotherapeutic process of inpatient psychosomatic treatment and its results: Could ASA be beneficial?]","authors":"Marius Binneböse, Jan Schott, Hannah Wallis, Christian Kaiser, Matthias Vogel","doi":"10.13109/zptm.2023.69.4.369","DOIUrl":null,"url":null,"abstract":"<p><p><b>Objectives:</b> Psychic perceptions are at the core of psychotherapeutic processes and modifiable by certain psychopharmacologic agents including antidepressants and cyclooxygenase (COX) inhibitors like acetylsalicylic acid (ASA). <b>Methods:</b> We analyzed the medical records of 208 participants, and used the weekly mean dosages and the number of weeks in therapy to predict ward experience (Stationserfahrungsbogen) and symptom burden (symptom-check list 90-R) by means of linear regression analyses and four repeated measures. <b>Results:</b> Time predicted symptom relief. ASA signified a more favorable ward experience and a trend towards less suffering. Antidepressants did not predict symptom burden or ward experience, except for amitriptyline's inverse relationship with process perception. <b>Discussion:</b> Regarding process perception and therapy outcome, amitriptyline might have unfavorable effects at dose reductions, whereas COX-inhibition could be beneficial at higher dosages. Similar findings have already been described with regard to COX-inhibition in depression and schizophrenia.</p>","PeriodicalId":51217,"journal":{"name":"Zeitschrift Fur Psychosomatische Medizin Und Psychotherapie","volume":"69 4","pages":"369-382"},"PeriodicalIF":0.8000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Zeitschrift Fur Psychosomatische Medizin Und Psychotherapie","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.13109/zptm.2023.69.4.369","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives: Psychic perceptions are at the core of psychotherapeutic processes and modifiable by certain psychopharmacologic agents including antidepressants and cyclooxygenase (COX) inhibitors like acetylsalicylic acid (ASA). Methods: We analyzed the medical records of 208 participants, and used the weekly mean dosages and the number of weeks in therapy to predict ward experience (Stationserfahrungsbogen) and symptom burden (symptom-check list 90-R) by means of linear regression analyses and four repeated measures. Results: Time predicted symptom relief. ASA signified a more favorable ward experience and a trend towards less suffering. Antidepressants did not predict symptom burden or ward experience, except for amitriptyline's inverse relationship with process perception. Discussion: Regarding process perception and therapy outcome, amitriptyline might have unfavorable effects at dose reductions, whereas COX-inhibition could be beneficial at higher dosages. Similar findings have already been described with regard to COX-inhibition in depression and schizophrenia.
期刊介绍:
This journal provides a systematic overview of the entire field of psychosomatic medicine. It is also the official organ of the German Society for Psychosomatic Medicine and Medical Psychotherapy (DGPM). It serves as a forum for discussions of the interdisciplinary experiences in the field of psychosomatics, the goal being the furtherance of scientific insights into the interactions between mental and physical factors in the development of disease. It also provides a way to deepen one´s knowledge of psychoanalysis and to explore new therapeutic directions.